000 | 01973 a2200517 4500 | ||
---|---|---|---|
005 | 20250514231626.0 | ||
264 | 0 | _c20051107 | |
008 | 200511s 0 0 eng d | ||
022 | _a0301-2115 | ||
024 | 7 |
_a10.1016/j.ejogrb.2004.11.029 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSağsöz, Nevin | |
245 | 0 | 0 |
_aThe effects of hormone therapy, estrogen therapy and tibolone on apoptosis and cyclin D1 expression in postmenopausal vaginal epithelium. _h[electronic resource] |
260 |
_bEuropean journal of obstetrics, gynecology, and reproductive biology _cJul 2005 |
||
300 |
_a61-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aApoptosis _xphysiology |
650 | 0 | 4 |
_aBiomarkers _xanalysis |
650 | 0 | 4 | _aBiopsy, Needle |
650 | 0 | 4 |
_aCyclin D1 _xanalysis |
650 | 0 | 4 |
_aEpithelium _xdrug effects |
650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHormone Replacement Therapy _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNorpregnenes _xadministration & dosage |
650 | 0 | 4 |
_aPostmenopause _xdrug effects |
650 | 0 | 4 | _aProbability |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVagina _xdrug effects |
700 | 1 | _aYücel, Aykan | |
700 | 1 | _aNoyan, Volkan | |
700 | 1 | _aBozdoğan, Onder | |
773 | 0 |
_tEuropean journal of obstetrics, gynecology, and reproductive biology _gvol. 121 _gno. 1 _gp. 61-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejogrb.2004.11.029 _zAvailable from publisher's website |
999 |
_c15614802 _d15614802 |